Anbio Biotechnology (NNNN) Retained Earnings (2023 - 2025)

Anbio Biotechnology has reported Retained Earnings for 3 years, with the latest figure at $23.6 million in Q4 2025.

• On a quarterly basis, Retained Earnings rose 37.29% year-over-year to $23.6 million in Q4 2025; TTM through Dec 2025 was $23.6 million, a 37.29% increase from a year earlier, with the FY2025 full-year figure at $23.6 million, up 37.29% from the prior year.
• Retained Earnings was $23.6 million for Q4 2025 at Anbio Biotechnology, up from $21.0 million in the prior quarter.
• The five-year high for Retained Earnings was $23.6 million in Q4 2025, with the low at $14.8 million in Q4 2023.
• Average Retained Earnings over 3 years is $19.1 million, with a median of $19.1 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings climbed 16.03% in 2024, then surged 37.29% in 2025.
• Over 3 years, Retained Earnings stood at $14.8 million in 2023, then advanced by 16.03% to $17.2 million in 2024, then jumped by 37.29% to $23.6 million in 2025.
• The last three Retained Earnings figures came in at $23.6 million (Q4 2025), $21.0 million (Q2 2025), and $17.2 million (Q4 2024), per Business Quant data.